Lixte Biotechnology Inc.

NASDAQ: LIXT · Real-Time Price · USD
3.56
-0.34 (-8.72%)
At close: Aug 15, 2025, 3:59 PM
3.62
1.69%
After-hours: Aug 15, 2025, 05:16 PM EDT

Lixte Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-3.59M -5.09M -6.31M -6.73M
Depreciation & Amortization
n/a n/a n/a n/a
Stock-Based Compensation
418.42K 773.2K 1.55M 2.6M
Other Working Capital
3.01K 94.54K 150.96K -49.11K
Other Non-Cash Items
n/a n/a n/a n/a
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
3.01K 20.56K 154.76K -13.44K
Operating Cash Flow
-3.16M -4.29M -4.61M -4.14M
Capital Expenditures
n/a 5.00 -3 -5
Cash Acquisitions
n/a n/a 5.14M n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a 3.14M n/a n/a
Other Investing Acitivies
n/a -3.14M n/a n/a
Investing Cash Flow
n/a n/a 5.14M n/a
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a 6.32K n/a 207.63K
Financial Cash Flow
n/a 3.14M 5.14M 3.9M
Net Cash Flow
-3.16M -1.15M 529.65K -245.52K
Free Cash Flow
-3.16M -4.29M -4.61M -4.14M